Atlas Trials

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Clinical trial NCT01142193 · COMPLETED

Trial details

NCT number
NCT01142193
Sponsor
Upsher-Smith Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsy
Start date
2010-05-01
Primary completion
2012-12-01
Enrollment
249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.